FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula 1 or pharmaceutically acceptable derivatives thereof, where values of radicals X, W, R4, Ar1, Ar2, R3, R4, R20 are as described in paragraph 1 of the claim. The invention also describes a composition for treating or preventing pain, UI, ulcers, inflammatory bowel disease or irritable bowel syndrome.
EFFECT: compound which can be used in medicine is obtained and described.
46 cl, 10 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
MONOMER DERIVATIVES OF GLYCOPEPTIDE ANTIBIOTIC | 2005 |
|
RU2424248C2 |
PHARMACOLOGICALLY ACTIVE COMPOUNDS AS INHIBITORS OF THE TAM FAMILY RECEPTOR TYROSINE KINASE | 2016 |
|
RU2750727C2 |
COMBINATIONS OF ACTIVATOR (ACTIVATORS) OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR), AND INHIBITOR (INHIBITORS) OF STEROL ABSORPTION AND TREATMENT OF VASCULAR DISEASES | 2008 |
|
RU2483724C2 |
V1A-RECEPTORS AGONISTS | 2013 |
|
RU2634617C2 |
5-SUBSTITUTED ALKYLAMINOPYRAZOLE DERIVATIVES AS PESTICIDES | 2003 |
|
RU2308452C2 |
DERIVATIVES OF 5-SUBSTITUTED ALKYLAMINOPYRAZOLES AS PESTICIDES | 2003 |
|
RU2336272C2 |
SYNTHETIC METHOD OF REDUCING ALKYLATING OF INDOLES IN C-3-POSITION | 2004 |
|
RU2352560C2 |
NEW PHOSPHORUS-CONTAINING THYMOMIMETIC DRUGS | 2004 |
|
RU2422450C2 |
IMIDAZOLE DERIVATIVES | 1999 |
|
RU2263111C2 |
THIAZOLIDINONE COMPOUNDS AND USE THEREOF FOR TREATING MENTAL OR NEUROLOGICAL DISORDERS AND INFLAMMATION, PARTICULARLY NEUROINFLAMMATION | 2015 |
|
RU2734253C2 |
Authors
Dates
2012-06-10—Published
2008-04-25—Filed